US bombshell hits PM's China trip
Overnight on Sunday, Mr Colby, the US Undersecretary of Defence, said the US' position of 'achieving peace through strength' was 'abundantly and consistently clear,' and would include urging allies to 'step up their defence spending and other efforts related to our collective defence'.
This follows Mr Hegseth's call for Australia to boost immediately boost investment from 2 per cent to 3.5 per cent of GDP, about $40bn, significantly beyond Labor's current commitment to reach 2.33 per cent by 2033.
While Mr Colby, a noted China hawk, didn't name countries who are lagging on their funding commitments, he said the US would 'not be deterred'.
'Of course, some among our allies might not welcome frank conversations. But many, now led by NATO after the historic Hague Summit, are seeing the urgent need to step up and are doing so,' he wrote on X.
'President Trump has shown the approach and the formula – and we will not be deterred from advancing his agenda.'
Asked directly about Mr Colby's comments, Mr Albanese said 'I have discussions with people which are private and I keep it private,' and noted again that 'Australia is considerably increasing our defence spending'.
'I say the same thing privately as I say publicly, $57bn over 10 years, we are increasing our defense spending and investment by more than $10bn we have contributed as well to AUKUS already going forward, a billion dollars are being forwarded to help increase the industrial capacity in the United States and will continue to invest in whatever we need to improve our capability,' he said.
His comments follow reports in the Financial Times on Saturday that Mr Colby has been pushing Japanese and Australian defence officials on their response if China invaded Taiwan, an outcome US Defence Secretary Pete Hegseth said was an 'imminent' threat.
Quoting one US official, they told the UK publication that while the US does 'not seek war,' or to 'dominate China,' the US wants to ensure both it and its allies 'have the military strength to underwrite diplomacy and guarantee peace'.
Speaking to the ABC on Sunday, Acting Defence Minister Pat Conroy would not 'engage in hypotheticals' or 'disclose confidential discussions'.
'The sole power to commit Australia to war or to allow our territory to be used for a conflict is the elected government of the day,' he said.
'That is our position. Sovereignty will always be prioritised, and that will continue to be our position.'
Australia has repeatedly rebuffed calls from the US to boost defence spending, stating that the amount will be decided according to Australia's sovereign needs, which has in-turn put pressure on the alliance, and Mr Albanese's attempts to secure a tariff exemption.
While politically, Mr Albanese is under increasing pressure to secure a meeting with Mr Trump, the leaders are set to have a face-to-face talk in early September during the Quad meeting in India.
This will also be the first in-person meeting between Mr Albanese and Mr Trump since the President's re-election in November, however the leaders have shared three phone calls.
Echoing comments made by Mr Albanese, Foreign Minister Penny Wong last week said that said Australia's security should not be defined 'simply in the terms of what China or the United States is doing in the regions'.
'Instead Australia will 'take our own approach to our relationships, to the rules and to this region that we share,' she said while attending the ASEAN Summit in Malaysia.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNBC
31 minutes ago
- CNBC
New Senate report on Trump assassination attempt calls for more severe disciplinary action
A new Senate report on the attempted assassination of President Donald Trump at a campaign rally in Butler, Pennsylvania, last summer has revealed "multiple, unacceptable failures" in the U.S. Secret Service's planning and response, and called for more severe disciplinary action. Trump, then a presidential candidate, was grazed by a bullet during the rally as 20-year-old gunman Thomas Crooks fired eight shots. One attendee, Corey Comperatore, was killed, and two others were injured. A sniper subsequently killed the gunman, but the attack prompted questions about how Crooks was able to avoid detection by the country's top protective agency for nearly 45 minutes. "What happened was inexcusable and the consequences imposed for the failures so far do not reflect the severity of the situation," stated the report released Sunday by the Homeland Security and Governmental Affairs Committee, chaired by Sen. Rand Paul, R-Ky. Last December, a House task force investigating the incident made nearly a dozen recommendations for the Secret Service in a 180-page report that determined the shooting was "preventable." The latest report details a series of breakdowns that reveal "a disturbing pattern of communication failure and negligence that culminated in a preventable tragedy." It said the USSS became aware of a suspicious individual "nearly 45 minutes before shots were fired, and failed to act." Despite advance knowledge of line-of-sight vulnerabilities at the venue, officials did not address them, the report said, adding the agency assigned an inexperienced operator to oversee counter-unmanned aerial systems and that USSS headquarters "denied or left-unfulfilled at least 10 requests" by the Donald Trump Division for additional resources, including countersniper personnel. Last July, six Secret Service employees were suspended without pay, an agency official told NBC News last week. The suspensions ranged from 10 to 42 days without pay. It is unclear when the agents were formally suspended. Less than two weeks after the incident, Kimberly Cheatle stepped down as director of the Secret Service amid bipartisan calls for her resignation. At the time, she said she took "full responsibility for the security lapse." But the report also criticized the agency for "insufficient accountability" following the attack. "Not a single person has been fired," it said. "The Committee believes more than six individuals should have received disciplinary action as a result of their action (or inaction) on July 13, 2024. Those who were disciplined received penalties far too weak to match the severity of the failures." Investigators also found that the Secret Service "denied or left unfulfilled" multiple requests for additional staff, assets and resources to protect Trump. "This was not a single error. It was a cascade of preventable failures that nearly cost President Trump his life," it said. "The American people deserve better." On Saturday, Senate Judiciary Committee Chairman Chuck Grassley, R-Iowa, released a separate Government Accountability Office report saying the USSS "failed to implement security measures that could have prevented the assassination attempt." "Prior to the July 13 rally, senior-level Secret Service officials became aware of a threat to then-former President Trump," the GAO report said. "This information was not specific to the July 13 rally or gunman. Nonetheless, due to the Secret Service's siloed practice for sharing classified threat information, Secret Service and local law enforcement personnel central to developing site security plans for the rally were unaware of the threat." In an interview with ABC News before she resigned, Cheatle said there was a "short period" of time between when the gunman was initially flagged as suspicious and when he began shooting. December's House investigation praised the response of the Secret Service to the second assassination attempt on Trump in September in West Palm Beach, Florida, crediting it for demonstrating "how properly executed protective measures can foil an attempted assassination."


Gizmodo
36 minutes ago
- Gizmodo
Trump Tries to Bury Epstein Scandal, but Elon Musk Won't Let Him
Elon Musk seems convinced he's finally found Donald Trump's Achilles' heel, the one issue that could fracture the unshakable loyalty of the Make America Great Again (MAGA) movement: the infamous Epstein files and their handling by the Trump administration. For years, the unsealing of Jeffrey Epstein's records has been a holy grail for many on the right. The belief, fanned by influencers now in seats of power, was that the files contained a secret 'client list' that would expose widespread corruption and depravity among powerful Democrats and 'deep state' figures. It was seen as the ultimate political weapon. FBI Director Kash Patel, in his former life as a right-wing media personality, told Glenn Beck in 2023 that Trump should 'on Day 1, roll out the 'black book'.' This long-held anticipation is what made the administration's recent announcement so explosive. On July 7, the Department of Justice and the FBI released a joint memo concluding their review found no mythical client list and no new information that could lead to charges. The long-awaited bombshell was a dud, and the fallout has been swift, creating deep fissures within the administration itself. According to multiple reports, a major fracture has emerged between the leadership of the DOJ and the FBI over the handling of the case files. The infighting boiled over when conservative commentator Dan Bongino, now the Deputy Director of the FBI, reportedly criticized Attorney General Pam Bondi's handling of the review in a White House meeting. Reports from Fox News and other outlets suggest Bongino distanced himself from the findings and is considering resigning in protest. Amid the chaos, FBI Director Kash Patel posted a carefully worded statement on X. 'The conspiracy theories just aren't true, never have been,' Patel wrote on July 12, without clarifying if he was denying reports about the feud or a potential Bongino resignation. 'It's an honor to serve the President of the United States @realDonaldTrump — and I'll continue to do so for as long as he calls on me.' The conspiracy theories just aren't true, never have been. It's an honor to serve the President of the United States @realDonaldTrump — and I'll continue to do so for as long as he calls on me. — Kash Patel (@Kash_Patel) July 12, 2025This internal revolt prompted President Trump to intervene. In a lengthy message on Truth Social, he attempted to shut down the controversy by framing the entire Epstein affair as a conspiracy orchestrated by his political enemies. 'They created the Epstein Files, just like they created the FAKE Hillary Clinton/Christopher Steele Dossier,' Trump wrote, urging his allies to stop 'playing right into their hands.' He ordered his team to refocus on his own political grievances and to 'not waste Time and Energy on Jeffrey Epstein, somebody that nobody cares about.' 'LET PAM BONDI DO HER JOB — SHE'S GREAT!' the president concluded. But where Trump saw a political inconvenience, Elon Musk, the CEO of Tesla and founder of SpaceX, saw a profound moral failure. In a direct reply on X, Musk ignored Trump's entire political narrative. Instead, he zeroed in on the core injustice of the scandal, amplifying the outrage that Trump sought to extinguish. 'This is a very big deal,' Musk posted to his hundreds of millions of followers. 'What the hell kind of system are we living in if thousands of kids were abused, the government has videos of the abusers and yet none of the abusers are even facing charges!?' This is a very big deal. What the hell kind of system are we living in if thousands of kids were abused, the government has videos of the abusers and yet none of the abusers are even facing charges!? — Elon Musk (@elonmusk) July 13, 2025The rebuke was immediate and powerful. While Trump tried to control his political universe, Musk used his immense platform to declare that justice for abused children was more important than political games. The split highlights a fundamental difference between the two men: Trump views the world through the lens of political power, while Musk, in this instance, has positioned himself as a champion for basic justice. This public disagreement marks one of the most significant moments of dissent from within Trump's orbit and appears to be the latest flashpoint in a rapidly escalating political divorce. Their once-tight alliance, which saw Musk lead a government efficiency task force (DOGE), has fractured in recent weeks over fundamental disagreements on policy. The rift burst into public view over Trump's 'One Big Beautiful Bill,' a sweeping tax and spending package that Musk lambasted as a 'disgusting abomination.' I'm sorry, but I just can't stand it anymore. This massive, outrageous, pork-filled Congressional spending bill is a disgusting abomination. Shame on those who voted for it: you know you did wrong. You know it. — Elon Musk (@elonmusk) June 3, 2025That policy disagreement quickly morphed into a direct political challenge. In early July, Musk announced the formation of 'America Party,' a third-party movement aimed at challenging the political establishment. The move was a clear signal that Musk was no longer content to be a Trump ally. While their previous fights were over fiscal policy and political strategy, this latest clash over Jeffrey Epstein is different. By refusing to let the Epstein story be swept under the rug, Musk is using his platform to force a conversation that Trump desperately wants to end, proving he is one of the few figures on the right willing and able to defy the president so directly.
Yahoo
an hour ago
- Yahoo
Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs.
When a U.S. president threatens your industry with a 200% tariff, that's not typically good news. But since Tuesday, when Donald Trump said in a cabinet meeting that imported pharmaceuticals would face a massive levy, investors have been cautiously celebrating. Despite a broad stock selloff on Friday, the NYSE Arca Pharmaceutical Index is up around 1% over the past week, compared with a basically flat performance for the S&P 500. Inside the Shadowy, Lucrative Business of 'Superfake' Luxury Handbags SpaceX to Invest $2 Billion Into Elon Musk's xAI The Best EV Deals Now Are on the Used Market That outperformance may seem puzzling, but for Wall Street, the size of the tariff matters less than the timing. The 200% figure lit up cable news chyrons, but investors focused instead on the grace period Trump floated. 'We're going to give people about a year, year and a half to come in, and after that, they're going to be tariffed,' he said. A year and a half is a long runway—and it could turn out to be even longer in practice. In a note titled 'Tariffs Schmariffs,' Jefferies analyst Akash Tewari argues that if the grace period begins some time this year and lasts for a year and a half, companies could continue importing drugs tariff-free until 2027. They could buy even more time if they stockpile during that period to cover demand at least until some time in 2028. That might give them time to build entirely new U.S. manufacturing facilities, which typically takes around four years. This doesn't mean Trump isn't getting what he wants. After all, the tariffs are meant as a threat to push companies to make more of their products in the U.S. And in this case, the threat seems to be working. Since Trump began threatening pharma with tariffs, the industry has moved on two fronts. First, companies have been stockpiling drugs at a furious pace to build a cushion. For instance, the Wall Street Journal reported last month that $36 billion worth of hormone treatments—used in popular obesity and diabetes drugs—have been shipped from Ireland this year, more than double last year's total. Second, the industry has announced major investments in U.S. manufacturing. Some of that may be political posturing, but much of it reflects a real shift. Companies increasingly see no choice but to bring production back, at least for drugs sold to American patients. Eli Lilly, for example, has announced a $27 billion plan to expand manufacturing in the U.S. Making drugs in the U.S.—and registering the intellectual property here—comes with a tax hit. That is a big reason the industry offshored production to low-tax countries like Ireland in the first place. But Trump's 'Big Beautiful Bill' offers some relief to offset the pain. The bill lets companies immediately deduct R&D expenses and equipment purchases and raises the cap on how much interest they can write off—making it a lot cheaper to build new plants at home. The upshot: with more time to prepare and a friendlier tax environment, pharma companies may barely feel the sting of tariffs. Take Merck. The company plans to produce a new version of its blockbuster drug Keytruda in the U.S. Jefferies estimates that with steps like stockpiling, gradually shifting production and trimming some costs, the hit to Merck's earnings from tariffs in 2027 and 2028 could be just 1% to 2%. That is actually better than Jefferies's earlier model for a smaller 25% tariff, which assumed fewer workarounds. The sense of a new normal settling in around Trump's second presidency might help explain why dealmaking has returned to the sector. Merck this past week announced a roughly $10 billion deal to buy Verona Pharma. That followed a series of other deal announcements, including Eli Lilly's $1.3 billion pact to acquire Verve Therapeutics. By the end of Trump's term, the U.S. pharmaceutical supply chain could look very different, with a greater share of innovative drug production happening on American soil. That would be a rare win-win—for the White House and for the industry. Write to David Wainer at Economists See Lower Recession Risk and Stronger Job Growth: WSJ Survey Can Pittsburgh's Old Steel Mills Be Turned Into an AI Hub? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data